Elutia Inc. Market Cap ($35.87 Million)
Market Cap & Net Worth: Elutia Inc. (ELUT)
Elutia Inc. market cap. Elutia Inc. (NASDAQ:ELUT) has a market capitalization of $35.87 Million ($35.87 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22921 globally and #5036 in its home market, demonstrating a 1.90% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elutia Inc.'s stock price $0.81 by its total outstanding shares 44289230 (44.29 Million). Also see cash flow conversion of Elutia Inc. for how efficiently the company converts equity into cash flow.
Elutia Inc. Market Cap History (2020–2026)
Elutia Inc. market cap history from 2020 to 2026. Data shows change from $603.66 Million to $36.02 Million (-37.77% CAGR). Check Elutia Inc. stock price for real-time trading data and today's change.
Index Memberships
Elutia Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #648 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2152 of 3165 |
Weight: Elutia Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Elutia Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elutia Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Elutia Inc. (ELUT) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.50x
Elutia Inc.'s market cap is 2.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.57x
Elutia Inc.'s market cap is 0.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $603.66 Million | $42.68 Million | -$21.82 Million | 14.14x | N/A |
| 2021 | $279.02 Million | $47.39 Million | -$24.83 Million | 5.89x | N/A |
| 2022 | $188.23 Million | $23.85 Million | -$32.90 Million | 7.89x | N/A |
| 2023 | $95.66 Million | $24.75 Million | -$37.66 Million | 3.87x | N/A |
| 2024 | $165.64 Million | $24.38 Million | -$53.95 Million | 6.80x | N/A |
| 2025 | $30.68 Million | $12.29 Million | $53.38 Million | 2.50x | 0.57x |
Competitor Companies of ELUT by Market Capitalization
Companies near Elutia Inc. in the global market cap rankings as of November 4, 2026. Also see Elutia Inc. asset portfolio for a full breakdown of the balance sheet.
Key companies related to Elutia Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Elutia Inc. (2020–2026)
Market capitalization of Elutia Inc. from 2020 to today. Between 2020 and today, Elutia Inc.'s market cap moved from $603.66 Million to $ 36.02 Million, with a yearly change of -37.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $36.02 Million | +17.40% |
| 2025 | $30.68 Million | -81.48% |
| 2024 | $165.64 Million | +73.15% |
| 2023 | $95.66 Million | -49.18% |
| 2022 | $188.23 Million | -32.54% |
| 2021 | $279.02 Million | -53.78% |
| 2020 | $603.66 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Elutia Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.87 Million USD |
| MoneyControl | $35.87 Million USD |
| MarketWatch | $35.87 Million USD |
| marketcap.company | $35.87 Million USD |
| Reuters | $35.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elutia Inc.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDer… Read more